Abstract
G A A b st ra ct s younger on average (65.5 ±10.7) than bleeding cases (70.0±11.4; p = 0.056). Conclusions: 1. The rate of gastrointestinal bleeding among patients on dual antiplatelet therapy after PCI with PPI co-therapy is 1.8 cases per 100 patient-years. 2. Most bleeding events occur during the first year of follow-up and are located in the lower GI tract. 3. Risk factors predictive of a bleeding event are co-therapy with warfarin, age and a peptic ulcer history.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
